OPTI OptiBiotix Health PLC
Financings ·
Optimi can sell shares to Seven Knots, LLC at its discretion, up to US$2 million per draw. It issued a US$1.5 million convertible note as a commitment fee.
The offering totals US$15,000,000 before fees. Optimi has been approved to list on the Nasdaq Capital Market under the symbol OPTH.
The British Columbia company plans a reverse share split and has applied to list on the Nasdaq Capital Market. Titan Partners Group is the sole bookrunner.
Our latest story on this, dated May 20, 2026: "Optimi Health prices US IPO of 2,400,000 shares at US$6.25". The story links the filing or release it is based on. Read the story.
Our latest story on this, dated May 20, 2026: "Optimi Health prices US IPO of 2,400,000 shares at US$6.25". The story links the filing or release it is based on. Read the story.
Our latest story on this, dated Aug 27, 2026: "Optimi Health sets up equity line to sell up to US$100 million of shares to Seven Knots". The story links the filing or release it is based on. Read the story.
OptiBiotix Health PLC trades under the ticker OPTI on LSE.
OptiBiotix Health PLC is listed on LSE.
Our directory records OptiBiotix Health PLC under United Kingdom.
Our directory classifies OptiBiotix Health PLC as: Biotechnology. This is a directory classification, not a description of the pipeline.
The ISIN recorded for OptiBiotix Health PLC is GB00BP0RTP38.
aibio.space lists OptiBiotix Health PLC among 2,820 public biotech companies and publishes its news here as stories appear.
Our latest story on OptiBiotix Health, dated Aug 27, 2026: "Optimi Health sets up equity line to sell up to US$100 million of shares to Seven Knots". Optimi can sell shares to Seven Knots, LLC at its discretion, up to US$2 million per draw. It issued a US$1.5 million convertible note as a commitment fee. Source.
From our story of May 20, 2026: The prospectus says the company has suffered recurring losses and has a net capital deficiency, and that these conditions raise substantial doubt about its ability to continue as a going concern. Source.
Companies in our directory listed in the same country and business area as OptiBiotix Health: OKYO Pharma, Vidac Pharma Holding Plc, Scancell Holdings Plc, Mereo BioPharma Group, Adaptimmune Therapeutics, COMPASS Pathways Plc.
Press Follow on this page to add OptiBiotix Health to your Following list, or subscribe to the aibio.space newsletter. We have published 3 stories naming OptiBiotix Health so far, in Financings.
Reported a financing. SEC Form 6-K. Source
Reported a reverse stock split. SEC Form 6-K. Source
Reported a financing. SEC Form 6-K. Source
Reported a reverse stock split. SEC Form 6-K. Source
Filed a final prospectus for a securities offering. SEC Form 424B4. Source
Filed a registration statement for a share offering. SEC Form F-1. Source
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio